Related content

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

By Kinoshita Taira   Nashimoto Atsushi   Yamamura Yoshitaka   Okamura Takeshi   Sasako Mitsuru   Sakamoto Junichi   Kojima Hiroshi   Hiratsuka Masahiro   Arai Kuniyoshi   Sairenji Motonori   Fukushima Norimasa   Kimura Hironobu   Nakajima Toshifusa  

Gastric Cancer, Vol. 7, Iss. 2, 2004-06 ,pp. : 104-109

Springer Publishing Company

Access to resources Recommend Favorite

Thymidine phosphorylase mRNA expression may be a predictor of response to postoperative adjuvant chemotherapy with S1 in patients with stage III colorectal cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2463-2468

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

By                          

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1253-1256

Spandidos Publications

Access to resources Recommend Favorite

Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients

By Emi Yasunori  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 254-259

Springer Publishing Company

Access to resources Recommend Favorite